Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics

Sievert K-D, Hansen T, Titze B, Schulz B, Omran A, Brockkötter L, Gunnemann A, Titze U (2022)
Diagnostics 12(5): 1146.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA 1.63 MB
Autor*in
Sievert, Karl-DietrichUniBi; Hansen, TorstenUniBi; Titze, Barbara; Schulz, Birte; Omran, Ahmad; Brockkötter, Lukas; Gunnemann, Alfons; Titze, UlfUniBi
Abstract / Bemerkung
Background: The diagnosis of prostate carcinoma (PCa) requires time- and material-consuming histopathological examinations. Ex vivo fluorescence confocal microscopy (FCM) can detect carcinoma foci in diagnostic biopsies intraoperatively. Methods: MRI-guided and systematic biopsies were identified in a dataset of our previously published study cohort. Detection rates of clinically relevant tumors were determined in both groups. A retrospective blinded trial was performed to determine how many tumors requiring intervention were detectable via FCM analysis of MRI-guided targeted biopsies alone. Results: MRI-guided targeted biopsies revealed tumors more frequently than systematic biopsies. Carcinomas in need of intervention were reliably represented in the MRI-guided biopsies and were identified in intraoperative FCM microscopy. Combined with serum PSA levels and clinical presentation, 91% of the carcinomas in need of intervention were identified. Conclusions: Intraoperative FCM analysis of MRI-guided biopsies is a promising approach for the efficient diagnosis of PCa. The method allows a timely assessment of whether a tumor disease requiring intervention is present and can reduce the psychological stress of the patient in the waiting period of the histological finding. Furthermore, this technique can lead to reduction of the total number of biopsies needed for the diagnosis of PCa.
Stichworte
confocal microscopy; prostate cancer; targeted biopsies; digital; pathology
Erscheinungsjahr
2022
Zeitschriftentitel
Diagnostics
Band
12
Ausgabe
5
Art.-Nr.
1146
eISSN
2075-4418
Page URI
https://pub.uni-bielefeld.de/record/2963815

Zitieren

Sievert K-D, Hansen T, Titze B, et al. Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics. Diagnostics. 2022;12(5): 1146.
Sievert, K. - D., Hansen, T., Titze, B., Schulz, B., Omran, A., Brockkötter, L., Gunnemann, A., et al. (2022). Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics. Diagnostics, 12(5), 1146. https://doi.org/10.3390/diagnostics12051146
Sievert, Karl-Dietrich, Hansen, Torsten, Titze, Barbara, Schulz, Birte, Omran, Ahmad, Brockkötter, Lukas, Gunnemann, Alfons, and Titze, Ulf. 2022. “Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics”. Diagnostics 12 (5): 1146.
Sievert, K. - D., Hansen, T., Titze, B., Schulz, B., Omran, A., Brockkötter, L., Gunnemann, A., and Titze, U. (2022). Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics. Diagnostics 12:1146.
Sievert, K.-D., et al., 2022. Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics. Diagnostics, 12(5): 1146.
K.-D. Sievert, et al., “Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics”, Diagnostics, vol. 12, 2022, : 1146.
Sievert, K.-D., Hansen, T., Titze, B., Schulz, B., Omran, A., Brockkötter, L., Gunnemann, A., Titze, U.: Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics. Diagnostics. 12, : 1146 (2022).
Sievert, Karl-Dietrich, Hansen, Torsten, Titze, Barbara, Schulz, Birte, Omran, Ahmad, Brockkötter, Lukas, Gunnemann, Alfons, and Titze, Ulf. “Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics”. Diagnostics 12.5 (2022): 1146.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2022-07-06T13:10:18Z
MD5 Prüfsumme
869e1675158a74cb8d89f45f01c7408e

Link(s) zu Volltext(en)
Access Level
OA Open Access
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 35626301
PubMed | Europe PMC

Suchen in

Google Scholar